All Stories

  1. Pharmaceutical Patents and IPR
  2. Cybersecurity and Compliance in Clinical Trials: The Role of Artificial Intelligence in Secure Healthcare Management
  3. Effective Integration of Artificial Intelligence and Blockchain Technologies for Empowerment of Drug Discovery and Development
  4. Nutritional Riches of Date Seeds (Phoenix dactylifera L.): A Treasure Trove of Bioactive Compounds, Antioxidants, and Therapeutic Potential
  5. Artificial Intelligence and Machine Learning Approaches in Radiology for Medical Imaging Diagnostics
  6. Cybersecurity, Research Data Management (RDM), and Regulatory Compliance in Clinical Trials
  7. Global Analysis of Regulatory Frameworks and Drug Safety Standards in the Drug Approval Process
  8. Innovative Immunoinformatics Tools for Enhancing MHC (Major Histocompatibility Complex) Class I Epitope Prediction in Immunoproteomics
  9. Leveraging Artificial Intelligence for Data Integrity, Transparency, and Security in Technology-enabled Improvements to Clinical Trial Data Management in Healthcare
  10. Quantum Computing in Drug Discovery Techniques, Challenges, and Emerging Opportunities
  11. Current 3D Printing Technologies and Their Potential Applications in Drug Delivery, Personalized Medicine & Pharmaceutical Sciences
  12. Emerging Technology of Pharmaceutical Compliance: Role of Automation Tools in Regulatory Affairs for Clinical Trials
  13. The Economics of Drug Development: A Comparison Between Orphan and Non-Orphan Drugs
  14. Cloud Computing Facilitating Data Storage, Collaboration, and Analysis in Global Healthcare Clinical Trials
  15. Immunoinformatics Approach for Optimization of Targeted Vaccine Design: New Paradigm in Clinical Trials and Healthcare Management
  16. The Role of Animal Models in Huntington's Disease Clinical Trials: Decoding Genetic, Non-Genetic, and Molecular Pathways
  17. Pharmacovigilance - Technological Advancements, Recent Developments and Innovations
  18. Next-Gen Health Informatics- Artificial Intelligence Powered Diagnosticsand Blockchain Enabled Data Integrity For Radiological Image Analysis
  19. The Economics of Oncology: Assessing the High Costs, Uncertain Value, Efficacy, Safety of Anticancer Drugs
  20. Intellectual Property Rights Effects on India's PharmaceuticalIndustry
  21. Immunoproteomics: A Review of Techniques, Applications, and Advancements
  22. Immunoproteomics: Approach to Diagnostic and Vaccine Development
  23. Copper Nanoparticles: Characterization, Synthesis, and Biological Activity – A Review
  24. Formulation Consideration of Medicated Chewing Gum: A Review
  25. Intellectual Property Rights: Protection of Biotechnological Inventions in India
  26. Drug Delivery System: A Novel Approach to Formulation Development
  27. Ab initio Structural Insights and Functional Analysis of Thioredoxin Glutathione Reductase from Schistosoma japonicum
  28. Computational Approach to Identify the Major Histocompatibility Complex Binding Antigenic Peptides from 'Ascariasis'
  29. Computational Comparative Homology Based 3D-structure Modelling of the HSp70 Protein from GWD
  30. Computational Sensitive Quantitative Predictions of MHC Binding Peptides from Dracunculus medinensis
  31. Identification of Antigenic Determinants, Solvent Accessibility and MHC Binders of Antigen NADH Dehydrogenase Subunit 5 from a Little Dragon from Medina (Dracunculusmedinensis)
  32. Prediction of Antigenic MHC Peptide Binders and TAP Binder of COX1 Protein through In Silico Approach
  33. Prediction of MHC Binding Peptides and Antigenic Peptides from Ascaris lumbricoides
  34. Study Hydrophobicity and Antigenicity of Cytochrome C Oxidase Subunit II from D. medinensis: New Prototype of Synthetic Vaccine Development
  35. Study of Hydrophobicity and Prediction of Antigenic Epitope of NADH dehydrogenase subunit 5 from D. medinensis
  36. Study of Solvent Accessible Regions ,Hydrophobicity and Antigenicity of NADH dehydrogenase subunit 3
  37. “Cytochrome B”- Analysis of Hydrophobicity, Surface Accessibility, Antigenicity and Prediction of MHC I and MHC II Binders from Dracunculiasis
  38. Information of Surface Accessibility of the Peptide Fragments of Coat Protein from Alfalfa mosaic virus (AMV) at the Physicochemical and Immunochemical Levels
  39. Chapter 12. Chemogenomics
  40. Description on Tylocephalum salunkhi N. Sp. (Cestoda: Lecanicephalidea) and Study of Conserved Domain across Divergent Phylogenetic Lineages of Class Cestoda
  41. Evolutionary Distance and Conserved Domain Analysis of Divergent Phylogenetic Lineages from Genus Naja
  42. Identification of Antigenic Determinants, Solvent Accessibility and MHC Binders of Peb1a from Campylobacter jejuni
  43. Identification of Binding Affinity of TAP Peptides for Development of Fragment based Vaccine from Long neurotoxin 2 [N. naja]
  44. Identification of MHC Class, Transports Antigenic Peptides from Naja melanoleuca Long Neurotoxin 1
  45. Immunoproteomics: current approach for subunit vaccine design
  46. Prediction of Antigenic Peptide and MHC Binder from ITX-3 Tegenaria agrestis: Current Approach for Synthetic Vaccine Development
  47. Prediction of MHC Class Binding Peptide and High Affinity TAP Binders to Design Synthetic Peptide Vaccine of Long Neurotoxin 3 from Naja Naja
  48. Quantitative Immunoproteomics Approach for the Development of MHC Class I Associated Peptide Antigens of Alpha-Cobra Toxin from Naja kaouthia
  49. Redescription on Raillietina echinobothrida (Pasquale, 1890) (Cestoda:Davaineidae) and Study of Conserved Domain across Divergent Phylogenetic Lineages of Class Cestoda
  50. Study of Conserved Domain across Divergent Phylogenetic Lineages of Long Neurotoxin from Genus Naja (Elapidae Family)
  51. Prediction of Brugia malayi Antigenic Peptides: Candidates for Synthetic Vaccine Design Against Lymphatic Filariasis
  52. You are the Foremost Responder - What to do or not to do is the Question?
  53. Prediction of Wuchereria Bancrofti Troponin Antigenic Peptides: Application in Synthetic Vaccine Design to Counter Lymphatic Filariasis
  54. IN-SILICO APPROACH FOR PREDICTION OF VACCINE POTENTIAL ANTIGENIC PEPTIDES FROM 23-kDa TRANSMEMBRANE ANTIGEN PROTEIN OF Schistosoma haematobium
  55. An Immunoinformatics Approach to Design Synthetic Peptide Vaccine from Dendroaspis polylepis polylepis Dendrotoxin-K(DTX-K)
  56. Microbial Proteomics Approach for Sensitive Quantitative Predictions of MHC Binding Peptide from Taenia Ovis
  57. Prediction of MHC Class Antigen Peptides from Echinococcus Multilocularis: Application of Computer Intelligence
  58. Prediction of Major Histocompatibility Complex Binding Peptides and Epitopes from Fatty-Acid-Binding Protein of the Human Blood Fluke Schistosoma Japonicum
  59. Prediction of Major Histocompatibility Complex Binding Peptides and Epitopes from Neurotoxin of Mesobuthustamulus
  60. Sensitive Quantitative Predictions of MHC Binding Peptides and Fragment Based Peptide Vaccines from Taenia crassiceps
  61. METABOLIC DIVERSITY IN PLANTS
  62. Eimeria acervulina ANALYSIS FOR BINDING PEPTIDES USING PROTEIN PROFILING FOR TARGET VALIDATION
  63. Isolation, structure elucidation and biotransformation studies on secondary metabolites from Asparagus racemosus
  64. RNAI: GENE SILENCING APPROACH IN C. elegans and H. sapiens
  65. ROLE OF MHC RESTRICTION IN ALLOGENEIC IMMUNE RESPONSES TO CANCER
  66. STUDY OF PROTEIN METABOLISM OF GALLUS GALLUS DOMESTICUS (LINN, 1758) INFECTED BY RAILLIETINA (EUCESTODA)
  67. TOXICOGENOMICS AND ITS APPLICATION IN CANCER PATHOGENESIS
  68. Water-Hydrophobic Compound Interactions with the Microbial Cell
  69. Study of molecular evolution between plants and microbes
  70. IMMUNOINFORMATICS AND ITS ROLE IN MICROBES AND VACCINES
  71. Immunogenomics: recent discoveries
  72. MACHINE INTELLIGENCE APPROACH FOR OPTIMIZATION OF CRANIAL TUMOR IMAGE
  73. MALDI-TOF based Metabolomic approach
  74. Micro-RNA in development
  75. Oncoproteomics: New trends in analytical techniques
  76. Proteins as biocatalysts and biomaterials
  77. Proteins bioassay: recent scenario for new target validations
  78. Proteomics: Emerging analytical techniques
  79. APPLICATION OF DATA MINING FOR DEVELOPMENT OF SYNTHETIC VACCINE FROM SCORPION TOXIN
  80. MACHINE INTELLIGENT APPROACH FOR MAPPING OF MHC CLASS BINDING NONAMERS
  81. Phospho-onco-proteomics
  82. In silico Study of tertiary structure and binding interaction of Profilin – Schizosaccharomyces pombe
  83. IMMUNOPROTEOMICS APPROACH FOR FRAGMENT BASED VACCINE DESIGN FROM Coxsackie B virus
  84. Immunoproteomics approach for prediction of antigenic epitope of Tertiapin from Apis mellifera
  85. MACHINE INTELLIGENCE APPROACH FOR PREDICTION OF MHC BINDER FROM Human papilloma virus- 16
  86. Machine Learning Techniques: Approach for Mapping of MHC Class Binding Nonamers
  87. PREDICTION OF ANTIGENIC PEPTIDES OF LASIOTOXIN-2 (LPTX2) FROM LASIODORA PARAHYBANA
  88. Prediction of antigenic peptides of LTx5 toxin from Lasiodora sp. IBSP8539
  89. Proteomics approach for prediction of immunogenic site from Footand- mouth disease virus
  90. Proteomics based prediction of antigenicity of iberiotoxin from eastern Indian scorpion
  91. STUDY OF MOLECULAR SURFACE PROPERTY OF PHOSPHOLIPASE A2 (PLA2) FROM NAJA NAJA
  92. microRNA: human disease and development
  93. Phylogenomics: evolution and genomics intersection
  94. Cellunomics: the interaction analysis of cells
  95. Nutrigenomics
  96. Pathway Modeling: New face of Graphical Probabilistic Analysis
  97. Prediction of MHC Binding Peptides and Epitopes from Groundnut Bud Necrosis Virus (GBNV)
  98. Editorial [ Omics: An Approach for Drug Targets Guest Editor: Virendra S. Gomase Co-Guest Editor: Somnath Tagore ]
  99. Clonetics
  100. Species Scaling and Extrapolation
  101. Oncogenomics
  102. Pharmacogenomics
  103. Proteomics: Technologies for Protein Analysis
  104. Microarray: An Approach for Current Drug Targets
  105. Epigenomics
  106. Blood Stage Parasites: Sufficient to Induce Protective Immunity
  107. RNAi – A Tool for Target Finding in New Drug Development
  108. Transcriptomics
  109. Toxicogenomics
  110. Kinomics
  111. Physiomics
  112. Cytomics
  113. Metabolomics
  114. Computer Aided Multi Parameter Antigen Design: Impact of Synthetic Peptide Vaccines from Soybean Mosaic Virus
  115. Antigenicity prediction in melittin
  116. Prediction of antigenic MHC binders of neurotoxin M14 protein from Buthus eupeus
  117. Study of MHC nonamers and TAP activity of tertiapin from Apis mellifera
  118. Prediction of MHC Binding Peptides and Epitopes from Alfalfa mosaic virus
  119. Antigenicity Prediction in Melittin: Possibilities of in Drug Development from Apis dorsata
  120. DNA Electronics: A Nanotechnology Approach
  121. Automatic modelling of protein 3D structure Nucleoplasmin-like viral coat protein from Cucumber mosaic virus
  122. Prediction of Antigenic Epitopes of Neurotoxin Bmbktx1 from Mesobuthus martensii
  123. Chemogenomics
  124. Poster Session I Abstracts
  125. Poster Session II Abstracts